These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 24367043

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.
    Bernard V, Lombard-Bohas C, Taquet MC, Caroli-Bosc FX, Ruszniewski P, Niccoli P, Guimbaud R, Chougnet CN, Goichot B, Rohmer V, Borson-Chazot F, Baudin E, French Group of Endocrine Tumors.
    Eur J Endocrinol; 2013 May; 168(5):665-74. PubMed ID: 23392213
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glycemic control in patients with insulinoma treated with everolimus.
    Kulke MH, Bergsland EK, Yao JC.
    N Engl J Med; 2009 Jan 08; 360(2):195-7. PubMed ID: 19129539
    [No Abstract] [Full Text] [Related]

  • 8. Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma.
    Ong GS, Henley DE, Hurley D, Turner JH, Claringbold PG, Fegan PG.
    Eur J Endocrinol; 2010 May 08; 162(5):1001-8. PubMed ID: 20164213
    [Abstract] [Full Text] [Related]

  • 9. Successful control of intractable hypoglycemia using radiopharmaceutical therapy with strontium-89 in a case with malignant insulinoma and bone metastases.
    Naganuma A, Mayahara H, Morizane C, Ito Y, Hagihara A, Kondo S, Ueno H, Itami J, Okusaka T.
    Jpn J Clin Oncol; 2012 Jul 08; 42(7):640-5. PubMed ID: 22525212
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prompt resolution of hypoglycemia by hepatic transarterial embolization for malignant insulinoma with multiple liver metastases.
    Muro S, Nasu J, Harada R, Matsubara M, Nakarai A, Kanzaki H, Tsutsumi K, Kato H, Tanaka T, Fujiwara H, Uno M, Okada H, Yamamoto K.
    Acta Med Okayama; 2014 Jul 08; 68(5):303-6. PubMed ID: 25338488
    [Abstract] [Full Text] [Related]

  • 13. New therapeutic options for metastatic malignant insulinomas.
    de Herder WW, van Schaik E, Kwekkeboom D, Feelders RA.
    Clin Endocrinol (Oxf); 2011 Sep 08; 75(3):277-84. PubMed ID: 21649688
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Successful everolimus treatment in a patient with advanced pancreatic neuroendocrine tumor who developed everolimus-induced interstitial lung disease on two occasions: a case report.
    Nakayama Y, Ikeda M, Kojima M, Goto K, Hara M, Okuyama H, Takahashi H, Ohno I, Shimizu S, Mitsunaga S, Okusaka T.
    Chemotherapy; 2013 Sep 08; 59(1):74-8. PubMed ID: 23867634
    [Abstract] [Full Text] [Related]

  • 17. Sporadic insulinoma in a 10-year-old boy: a case report and literature review.
    Abu-Zaid A, Alghuneim LA, Metawee MT, Elkabbani RO, Almana H, Amin T, Azzam A.
    JOP; 2014 Jan 10; 15(1):53-7. PubMed ID: 24413786
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Advanced malignant insulinoma. Everolimus response and toxicity.
    Cuesta Hernández M, Gómez Hoyos E, Marcuello Foncillas C, Sastre Valera J, Díaz Pérez JÁ.
    Endocrinol Nutr; 2014 Jan 10; 61(1):e1-3. PubMed ID: 23999009
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.